177lu-psma-617,olaparib
novartis,merck,astrazeneca
['luparp', 'prostate', '177lu,psma,617', 'psma-617 ', 'olaparib']
june 4th see luparp: phase 1 trial of 177lu-psma-617 and olaparib in patients with metastatic castration resistant #prostatecancer with #pcffunded presenter shahneen sandhu, mbbs ( ) #asco2023 
The official Twitter account for scientific news from the Prostate Cancer Foundation. Follow us at @PCFNews